News & Events
All News
-
LabCentral Alum, Platelet BioGenesis. Raises $26 Million in Series A-1 Financing
September 10, 2019 -
SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors
September 06, 2019 -
LabCentral Appoints Biotech Industry Luminary Dr. Susan Windham-Bannister to its Board of Directors
September 05, 2019 -
HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
September 04, 2019 -
Novo Nordisk to award promising start-ups free space at Boston's premier, biotech-capable shared lab facility
August 15, 2019 -
Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer
July 17, 2019 -
LabCentral Alum, rare disease biotech Fulcrum Therapeutics sets terms for $77 million IPO
July 09, 2019 -
#OfficeEnvy: How LabCentral Designs For Scientific Collaboration
BostonInno
July 03, 2019
-
Bristol Myers-Squibb LabCentral 'Golden Ticket' Submission
July 03, 2019 -
Pfizer Opens Call for Proposals for Start-ups to Apply for LabCentral Residency
June 27, 2019